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Abstract:
Hypoxia is a condition where oxygen is unable to reach tissues and cells. When these
areas become oxygen deprived, they are unable to synthesize reactive oxygen species
(ROS), in whose absence, specific enzymes become overexpressed. Nitroreductase is
a protein commonly found in areas where hypoxic tumors are located and also where
many cancer forms occur. Nitroreductase is a good indicator of hypoxic tumors and can
be detected by molecular probes. One of the few synthesized probes termed compound
12 is highly tumor specific and enable visualization of pancreatic cancer at four different
levels of structure. Compound 12 works by fluorescing in pancreatic cancer cell,
indicating regions where metastasis and abnormal development is occurring. We are
also synthesizing a derivative of compound 12 by adding a nitro(-NO2) group.
Derivative compound 12 has a strong potential to enhance the visualization of not only
pancreatic cancer, but also cancer throughout the body and provide, therapeutic
monitoring, and aid to surgeons in margin assessment.

Background Information:
Pancreatic cancer affects more than 53,000 people in the United States. Scientist and
researchers estimate that pancreatic cancer may soon be the second leading cause of
disease-related death by 2030 (Wang, 2017). Also, what makes pancreatic cancer so

dangerous is that people have a post-diagnosis life expectancy of 5-7 months.
Pancreatic cancer is correlated with hypoxic environments and the overexpression of
enzymes like nitroreductase.

Hypoxic tumor cells are deprived of oxygen. In cancer patients, as the tumor grows, the
mass begins to outgrow its blood supply, leaving some regions with oxygen
concentrations lower than average. This inhibits the synthesis of enzymes and
coenzymes for metabolic function. Hypoxia can be harmful to both cancer cells and
healthy cells undergoing genetic and adaptive changes that increases survival and
growth rate (Harris, 2002).

It is also important to note the physiological and morphological changes in the
vasculature of these areas. Typically, in cancer cells, and especially pancreatic cancer,
they are growing and expanding the tumors, the oxygen supply will surpass oxygen
demand and eventually the distance between cells and vasculature increases,
complicating oxygen diffusion and creating an even more hypoxic environment (Muz,
2015). This can be locally detrimental and can spread, infecting other parts of the body.
Also, hypoxic tumor cells have a higher resistance towards cancer treatments and are
more likely to metastasize (Guo, 2013).

Nitroreductase, which is commonly overexpressed where oxygen is in low abundance,
is a crucial protein. It helps cells reduce nitrogen compounds. What makes
nitroreductase a vital enzyme to understand is that it’s generally found in hypoxic cells

where they can flow in blood vessels, making it difficult to target with selective drugs
(Denny, 2000). This leads to cells becoming resistant to chemotherapy and radiation.
By using molecular probes, one can select regions high in nitroreductase accurately. An
example of a molecular probe is determined by compound 12. Compound 12 has highly
attractive characteristics such as high contrast, and pancreas tumor specificity (Wang,
2017). With these regions highly fluorescent, they can potentially provide surgeons a
guided surgery through live imaging and enhance the detection of pancreatic cancer
(Wang, 2017).

Methods:
Molecular probes can be challenging to design, synthesize and evaluate. Examples of
potential properties can include reacting to different hypoxic environments and various
levels of structure. While compound 12 selectively target pancreatic cancer cells, the
derivative compound 12 was synthesized to target other regions that could be
expressing forms of cancer.

Figure 1. The chemical structures and physiochemical properties of compound 12 (Wang, 2017)

To synthesize both the probes, a variety of techniques were involved that began with
the condensation of hydroxybenzophenones with naphthols in a mixture of

CH3SO3H/TFA in a 1:1 ratio. A temperature of 80C was maintained for 16-24 hours to
produce lactones or carboxylates. After this was accomplished, we followed with fischer
esterifications to produce methyl derivatives, which was then carried out my methanol
and catalyzed by either hydrochloric acid or sulfuric acid. We further the process by
treating either the carboxylate or methyl ester derivative with methyl iodide while in the
presence of potassium carbonate in dimethylformamide to produce the methyl ethers.
The base structure for both the compound should be exactly the same, the only
difference is in the end. For compound 12, we attached a methoxy group towards the
end, where as in the derivate compound 12, we attached a nitro group instead. Lastly,
the compounds were purified and isolated by column chromatography along with the
characterization through NMR and mass spectrometry.

Figure 2. Compounds that were involved in the synthesis and the modifications had to be done in
a benzene substitution (Wang, 2017).

The compounds were analyzed using NMR or nuclear magnetic resonance
spectroscopy. The NMR spectrometers help identify the types of compounds present in
the mixture and if there are impurities. To use the NMR spectrometer, a small sample of
our product is collected in a tube and placed in a giant magnet. The results are
displayed on a computer screen and will show the different resonance(peaks)
associated with the various compounds to enable assignment of the product structure.

Fluorescence Spectroscopy and Ultraviolet-Visible Spectroscopy are used to determine
the optical properties of the fluorophores. Fluorescence Spectroscopy analyzes the
fluorescence emitted from the sample. Ultraviolet-Visible Spectroscopy examines the
absorption of light by the sample. Typically, Ultraviolet-Visible Spectroscopy and
fluorescence spectroscopy are used together in analyzing the compounds.
Fluorescence spectroscopy measures the transitions from the excited state to ground
state; whereas in Ultraviolet-Visible Spectroscopy, it measures the changes from
ground state to excited state.

Figure 3. This figure shows the final structure obtained once the reaction had been
completed.

Figure 4. The fluoresce emission of compound 12 in the healthy mouse cell line (Wang, 2017).

Results:
Compound 12 was tested on a mouse Pancreatic Ductal Adenocarcinoma (PDAC) cell
line known as Capan-1. The molecular probe showed high selectivity to fluoresce in the
mitochondria and also slightly in the nucleus and endoplasmic reticulum. The reason
why compounds 12 fluoresce in the mitochondrial environment is that the structure is
considered cationic, and thus distribute in the mitochondrial matrix due to the electric
potential across the mitochondrial membrane (Wang, 2017).

Figure 5. This figure represents the intensity of each fluorescent probes in various organs of a
healthy mouse (Wang, 2017).

The compound 12 was tested on mice with an oncogenic mutation termed KRAS. The
mice that expressed KRAS developed similar symptoms to Pancreatic Ductal
Adenocarcinoma seen in human cancer patients. The approval for the use of such
animals was obtained by The Institutional Animals Care and Use Committee (IACUC) at
OHSU. Microscopic images provide a real-time comparison between the molecular
probes and color. What we found was that the compound 12, displayed a high
selectively for these cancerous tissues seen in pancreatic cancer. While the compound
12 shows high selectivity for regions expressing pancreatic cancer, the derivative of
compound 12 is still in process of testing and analyzing.

Figure 6. These images represent microscopic images of compound 12 stained on pancreatic
tissues (Wang, 2017).

Discussion:
The synthesis of the compound 12 provides insightful knowledge on the imaging of
pancreatic cancer through molecular probes. Compound 12 provides high resolution
and selectivity in cancerous tissues, identifying distinctions between individual cell
morphologies. This project is vital to the understanding of pancreatic cancer and how
these areas can be determined. These probes can serve in the medical community for
imaging disease-relevant cancer. Also, clinicians and researchers can apply these
probes to biomedical research to better understand the development of tumors. This will
allow for more accurate treatment plans and an accurate perspective on the past of the
tumors. Overall, compound 12 is pancreas tumor-specific and can help the medical
community, promoting enhanced pancreatic cancer detection, therapeutic monitoring,
and research.
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